• Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts

    المصدر: Buzz FX / 01 يناير 2025 02:41:13   America/New_York


    Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat January 1, 2025 Share Link copied to clipboard. Sarepta Therapeutics, Inc. ( NASDAQ:SRPT - Get Free Report ) has been g
    Read more...
شارك على،